Identification |
Name: | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4,11-diethyl-4-hydroxy-,(4S)- |
Synonyms: | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4,11-diethyl-4-hydroxy-, (S)-;7-Ethyl-20(S)-camptothecin;SN 22; |
CAS: | 78287-27-1 |
Molecular Formula: | C22H20N2O4 |
Molecular Weight: | 376.4 |
InChI: | InChI=1/C22H20N2O4/c1-3-12-13-7-5-6-8-17(13)23-19-14(12)10-24-18(19)9-16-15(20(24)25)11-28-21(26)22(16,27)4-2/h5-9,27H,3-4,10-11H2,1-2H3/t22-/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.43 g/cm3 |
Refractive index: | 1.712 |
Appearance: | light pink solid |
Specification: | Light Pink Solid usageEng:An anticancer drug, showed strong activity against various murine tumors. A Camptothecin (CPT) derivative as antineoplastic agent against drug-resistant tumors. |
Usage: | An anticancer drug, showed strong activity against various murine tumors. A Camptothecin (CPT) derivative as antineoplastic agent against drug-resistant tumors. |
Safety Data |
|
|